Kini, A A <br/><br/>
Managing the high-risk patient: experience with fenoldopam, a selective dopamine receptor agonist, in prevention of radiocontrast nephropathy during percutaneous coronary intervention.  [electronic resource] 

 -  Reviews in cardiovascular medicine  2001 
 - S19-25 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1530-6550 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Kidney Injury--chemically induced<br/>Aged<br/>Aged, 80 and over<br/>Angioplasty, Balloon, Coronary--adverse effects<br/>Chi-Square Distribution<br/>Contrast Media--adverse effects<br/>Coronary Angiography--adverse effects<br/>Coronary Disease--diagnostic imaging<br/>Creatinine--urine<br/>Dopamine Agonists--therapeutic use<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Female<br/>Fenoldopam--therapeutic use<br/>Follow-Up Studies<br/>Humans<br/>Kidney Function Tests<br/>Male<br/>Middle Aged<br/>Probability<br/>Prospective Studies<br/>Radiopharmaceuticals--adverse effects<br/>Risk Assessment<br/>Risk Factors<br/>Treatment Outcome